Literature DB >> 16159083

Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.

Robert Paul1, Uwe Koedel, Hans-Walter Pfister.   

Abstract

Bacterial meningitis is a medical emergency and is optimally managed in an intensive care environment. Despite the use of antibiotics, the prognosis of this disease is poor because of central nervous system complications such as brain edema formation, cerebrovascular alterations, intracranial hemorrhage, and hydrocephalus. Effective adjunctive therapies are still missing. Experimental studies with animal models have provided new insights into the pathophysiology during the acute phase of bacterial meningitis. In recent years, knockout mice have become a powerful tool to investigate the role of particular genes and have also been applied in bacterial meningitis research. The use of these mice offered new insights into the role of different cytokines, proteases, and oxidants involved in the inflammatory cascade. Translating this knowledge into new therapies will provide new treatment strategies for this serious disease in the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16159083     DOI: 10.1385/NCC:2:3:313

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  128 in total

Review 1.  Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes.

Authors:  W A Muller; G J Randolph
Journal:  J Leukoc Biol       Date:  1999-11       Impact factor: 4.962

Review 2.  Overview of interleukin-18: more than an interferon-gamma inducing factor.

Authors:  C A Dinarello; D Novick; A J Puren; G Fantuzzi; L Shapiro; H Mühl; D Y Yoon; L L Reznikov; S H Kim; M Rubinstein
Journal:  J Leukoc Biol       Date:  1998-06       Impact factor: 4.962

Review 3.  The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases.

Authors:  C C Linder
Journal:  Lab Anim (NY)       Date:  2001-05       Impact factor: 12.625

Review 4.  Poly(ADP-ribose) polymerase inhibitors.

Authors:  Garry J Southan; Csaba Szabó
Journal:  Curr Med Chem       Date:  2003-02       Impact factor: 4.530

5.  Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes.

Authors:  Rogier J L Stuyt; Mihai G Netea; Teunis B H Geijtenbeek; Bart Jan Kullberg; Charles A Dinarello; Jos W M van der Meer
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

6.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

7.  Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.

Authors:  S Mun-Bryce; G A Rosenberg
Journal:  Am J Physiol       Date:  1998-05

8.  Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids.

Authors:  D Leppert; S L Hauser; J L Kishiyama; S An; L Zeng; E J Goetzl
Journal:  FASEB J       Date:  1995-11       Impact factor: 5.191

9.  First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes.

Authors:  K L Valentino; M Gutierrez; R Sanchez; M J Winship; D A Shapiro
Journal:  Int J Clin Pharmacol Ther       Date:  2003-10       Impact factor: 1.366

10.  Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats.

Authors:  H W Pfister; U Koedel; S Lorenzl; A Tomasz
Journal:  Stroke       Date:  1992-12       Impact factor: 7.914

View more
  5 in total

1.  Unusual cause of cerebral vasospasm after pituitary surgery.

Authors:  K A Popugaev; I A Savin; A U Lubnin; A S Goriachev; B A Kadashev; P L Kalinin; I N Pronin; A V Oshorov; M A Kutin
Journal:  Neurol Sci       Date:  2011-02-03       Impact factor: 3.307

Review 2.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

3.  Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis.

Authors:  Rahul Mittal; Ignacio Gonzalez-Gomez; Kerstin A Goth; Nemani V Prasadarao
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

4.  Cerebrospinal Fluid Presepsin As a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study.

Authors:  Sergey A Abudeev; Kirill V Kiselev; Nikolay M Kruglyakov; Ksenia A Belousova; Inna N Lobanova; Oleg V Parinov; Yuriy D Udalov; Maxim A Zabelin; Alexandr S Samoilov; Evaldas Cesnulis; Tim Killeen; Konstantin A Popugaev
Journal:  Front Neurol       Date:  2018-02-15       Impact factor: 4.003

5.  The causative pathogen determines the inflammatory profile in cerebrospinal fluid and outcome in patients with bacterial meningitis.

Authors:  Denis Grandgirard; Rahel Gäumann; Boubacar Coulibaly; Jean-Pierre Dangy; Ali Sie; Thomas Junghanss; Hans Schudel; Gerd Pluschke; Stephen L Leib
Journal:  Mediators Inflamm       Date:  2013-06-20       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.